Enzalutamide
Composition
The formulation contains Enzalutamide as the active ingredient.
Indications
Prostate cancer
Side effects
Fatigue, hypertension, hot flashes, seizures
Precautions
Monitor for signs of seizure activity and liver toxicity
Contraindications
Hypersensitivity to Enzalutamide or any component, history of seizures
Dosage and administration
As directed by oncologist
Countries
USA, UK, Australia
Available Forms
Oral capsule
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai